nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—Oxcarbazepine—epilepsy syndrome	0.32	1	CrCtD
Indapamide—CA4—epilepsy syndrome	0.129	1	CbGaD
Indapamide—Chlorthalidone—Clonazepam—epilepsy syndrome	0.0768	0.486	CrCrCtD
Indapamide—Oxcarbazepine—Carbamazepine—epilepsy syndrome	0.03	0.19	CrCrCtD
Indapamide—Oxcarbazepine—Clobazam—epilepsy syndrome	0.0265	0.168	CrCrCtD
Indapamide—Oxcarbazepine—Diazepam—epilepsy syndrome	0.0247	0.156	CrCrCtD
Indapamide—CA5B—Lacosamide—epilepsy syndrome	0.0163	0.0636	CbGbCtD
Indapamide—CA9—Lacosamide—epilepsy syndrome	0.014	0.0546	CbGbCtD
Indapamide—CA5A—Acetazolamide—epilepsy syndrome	0.0129	0.0503	CbGbCtD
Indapamide—CA4—Lacosamide—epilepsy syndrome	0.0123	0.048	CbGbCtD
Indapamide—CA5A—Zonisamide—epilepsy syndrome	0.0119	0.0465	CbGbCtD
Indapamide—CA2—Lacosamide—epilepsy syndrome	0.0113	0.0442	CbGbCtD
Indapamide—CA7—Acetazolamide—epilepsy syndrome	0.0112	0.0438	CbGbCtD
Indapamide—CA5B—Acetazolamide—epilepsy syndrome	0.0112	0.0438	CbGbCtD
Indapamide—CA5B—Zonisamide—epilepsy syndrome	0.0104	0.0405	CbGbCtD
Indapamide—CA7—Zonisamide—epilepsy syndrome	0.0104	0.0405	CbGbCtD
Indapamide—CA9—Acetazolamide—epilepsy syndrome	0.00962	0.0376	CbGbCtD
Indapamide—CA12—Acetazolamide—epilepsy syndrome	0.00962	0.0376	CbGbCtD
Indapamide—CA9—Zonisamide—epilepsy syndrome	0.0089	0.0348	CbGbCtD
Indapamide—CA12—Zonisamide—epilepsy syndrome	0.0089	0.0348	CbGbCtD
Indapamide—CA5A—Topiramate—epilepsy syndrome	0.00867	0.0339	CbGbCtD
Indapamide—CA4—Acetazolamide—epilepsy syndrome	0.00846	0.0331	CbGbCtD
Indapamide—CA4—Zonisamide—epilepsy syndrome	0.00783	0.0306	CbGbCtD
Indapamide—CA2—Acetazolamide—epilepsy syndrome	0.00778	0.0304	CbGbCtD
Indapamide—CA5B—Topiramate—epilepsy syndrome	0.00756	0.0295	CbGbCtD
Indapamide—CA7—Topiramate—epilepsy syndrome	0.00756	0.0295	CbGbCtD
Indapamide—CA2—Zonisamide—epilepsy syndrome	0.0072	0.0281	CbGbCtD
Indapamide—CA9—Topiramate—epilepsy syndrome	0.00649	0.0253	CbGbCtD
Indapamide—CA12—Topiramate—epilepsy syndrome	0.00649	0.0253	CbGbCtD
Indapamide—CA4—Topiramate—epilepsy syndrome	0.00571	0.0223	CbGbCtD
Indapamide—CA2—Topiramate—epilepsy syndrome	0.00525	0.0205	CbGbCtD
Indapamide—KCNE1—ear—epilepsy syndrome	0.00367	0.265	CbGeAlD
Indapamide—KCNQ1—ear—epilepsy syndrome	0.00169	0.121	CbGeAlD
Indapamide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00159	0.00622	CbGbCtD
Indapamide—CYP3A4—Trimethadione—epilepsy syndrome	0.00148	0.00578	CbGbCtD
Indapamide—CYP3A4—Felbamate—epilepsy syndrome	0.00148	0.00578	CbGbCtD
Indapamide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00139	0.00543	CbGbCtD
Indapamide—CYP3A4—Clonazepam—epilepsy syndrome	0.00126	0.00491	CbGbCtD
Indapamide—CYP3A4—Clobazam—epilepsy syndrome	0.00121	0.00471	CbGbCtD
Indapamide—CYP3A4—Rufinamide—epilepsy syndrome	0.00103	0.00401	CbGbCtD
Indapamide—CYP3A4—Carbamazepine—epilepsy syndrome	0.001	0.0039	CbGbCtD
Indapamide—CYP3A4—Primidone—epilepsy syndrome	0.000933	0.00364	CbGbCtD
Indapamide—CYP3A4—Phenytoin—epilepsy syndrome	0.000897	0.0035	CbGbCtD
Indapamide—CYP3A4—Propofol—epilepsy syndrome	0.000836	0.00327	CbGbCtD
Indapamide—CYP3A4—Phenobarbital—epilepsy syndrome	0.000799	0.00312	CbGbCtD
Indapamide—CYP3A4—Acetazolamide—epilepsy syndrome	0.000799	0.00312	CbGbCtD
Indapamide—CYP3A4—Midazolam—epilepsy syndrome	0.000788	0.00308	CbGbCtD
Indapamide—CYP3A4—Diazepam—epilepsy syndrome	0.000758	0.00296	CbGbCtD
Indapamide—CYP3A4—Zonisamide—epilepsy syndrome	0.000739	0.00289	CbGbCtD
Indapamide—CYP3A4—Valproic Acid—epilepsy syndrome	0.000597	0.00233	CbGbCtD
Indapamide—Bumetanide—SLC12A5—epilepsy syndrome	0.000553	0.296	CrCbGaD
Indapamide—KCNE1—head—epilepsy syndrome	0.000548	0.0395	CbGeAlD
Indapamide—CYP3A4—Topiramate—epilepsy syndrome	0.000539	0.0021	CbGbCtD
Indapamide—KCNE1—nervous system—epilepsy syndrome	0.00052	0.0375	CbGeAlD
Indapamide—CA4—ganglion—epilepsy syndrome	0.000463	0.0333	CbGeAlD
Indapamide—CA4—hindbrain—epilepsy syndrome	0.000351	0.0253	CbGeAlD
Indapamide—CA7—midbrain—epilepsy syndrome	0.000319	0.023	CbGeAlD
Indapamide—KCNQ1—medulla oblongata—epilepsy syndrome	0.000318	0.0229	CbGeAlD
Indapamide—CA12—forebrain—epilepsy syndrome	0.000314	0.0226	CbGeAlD
Indapamide—CA2—hindbrain—epilepsy syndrome	0.000291	0.021	CbGeAlD
Indapamide—CA12—telencephalon—epilepsy syndrome	0.000288	0.0208	CbGeAlD
Indapamide—Bumetanide—SLC12A2—epilepsy syndrome	0.00027	0.144	CrCbGaD
Indapamide—KCNQ1—head—epilepsy syndrome	0.000252	0.0181	CbGeAlD
Indapamide—CA7—cerebellum—epilepsy syndrome	0.000247	0.0178	CbGeAlD
Indapamide—CA9—cerebellum—epilepsy syndrome	0.000217	0.0156	CbGeAlD
Indapamide—CA4—brainstem—epilepsy syndrome	0.000201	0.0145	CbGeAlD
Indapamide—CA7—brain—epilepsy syndrome	0.0002	0.0144	CbGeAlD
Indapamide—Furosemide—CA4—epilepsy syndrome	0.000195	0.104	CrCbGaD
Indapamide—CA4—forebrain—epilepsy syndrome	0.000194	0.014	CbGeAlD
Indapamide—Metolazone—CA4—epilepsy syndrome	0.000188	0.1	CrCbGaD
Indapamide—KCNQ1—brain—epilepsy syndrome	0.000182	0.0131	CbGeAlD
Indapamide—CA12—head—epilepsy syndrome	0.00018	0.0129	CbGeAlD
Indapamide—CA4—telencephalon—epilepsy syndrome	0.000179	0.0129	CbGeAlD
Indapamide—CA12—nervous system—epilepsy syndrome	0.00017	0.0123	CbGeAlD
Indapamide—CA2—brainstem—epilepsy syndrome	0.000167	0.012	CbGeAlD
Indapamide—CA12—central nervous system—epilepsy syndrome	0.000164	0.0118	CbGeAlD
Indapamide—CA5B—head—epilepsy syndrome	0.000161	0.0116	CbGeAlD
Indapamide—CA2—forebrain—epilepsy syndrome	0.000161	0.0116	CbGeAlD
Indapamide—CA5B—nervous system—epilepsy syndrome	0.000153	0.011	CbGeAlD
Indapamide—Bumetanide—SLCO1A2—epilepsy syndrome	0.000149	0.0797	CrCbGaD
Indapamide—CA2—telencephalon—epilepsy syndrome	0.000148	0.0107	CbGeAlD
Indapamide—Bumetanide—CA4—epilepsy syndrome	0.000148	0.0791	CrCbGaD
Indapamide—CA5B—central nervous system—epilepsy syndrome	0.000147	0.0106	CbGeAlD
Indapamide—Chlorthalidone—CA4—epilepsy syndrome	0.000145	0.0775	CrCbGaD
Indapamide—CA4—medulla oblongata—epilepsy syndrome	0.00014	0.0101	CbGeAlD
Indapamide—CA12—brain—epilepsy syndrome	0.00013	0.00937	CbGeAlD
Indapamide—CA4—midbrain—epilepsy syndrome	0.000128	0.00924	CbGeAlD
Indapamide—CA4—spinal cord—epilepsy syndrome	0.000125	0.00901	CbGeAlD
Indapamide—CA5B—brain—epilepsy syndrome	0.000117	0.00841	CbGeAlD
Indapamide—CA2—medulla oblongata—epilepsy syndrome	0.000116	0.00838	CbGeAlD
Indapamide—CA4—head—epilepsy syndrome	0.000111	0.00801	CbGeAlD
Indapamide—CA2—midbrain—epilepsy syndrome	0.000106	0.00766	CbGeAlD
Indapamide—CA4—nervous system—epilepsy syndrome	0.000105	0.00759	CbGeAlD
Indapamide—CA2—spinal cord—epilepsy syndrome	0.000104	0.00747	CbGeAlD
Indapamide—CA4—central nervous system—epilepsy syndrome	0.000102	0.00731	CbGeAlD
Indapamide—CA4—cerebellum—epilepsy syndrome	9.92e-05	0.00715	CbGeAlD
Indapamide—Furosemide—ABCC2—epilepsy syndrome	9.42e-05	0.0503	CrCbGaD
Indapamide—CA2—head—epilepsy syndrome	9.22e-05	0.00664	CbGeAlD
Indapamide—CA2—nervous system—epilepsy syndrome	8.74e-05	0.0063	CbGeAlD
Indapamide—CA2—central nervous system—epilepsy syndrome	8.42e-05	0.00606	CbGeAlD
Indapamide—CA2—cerebellum—epilepsy syndrome	8.23e-05	0.00593	CbGeAlD
Indapamide—CA4—brain—epilepsy syndrome	8.06e-05	0.0058	CbGeAlD
Indapamide—CA2—brain—epilepsy syndrome	6.68e-05	0.00481	CbGeAlD
Indapamide—CYP3A4—nervous system—epilepsy syndrome	5.64e-05	0.00406	CbGeAlD
Indapamide—CYP3A4—central nervous system—epilepsy syndrome	5.43e-05	0.00391	CbGeAlD
Indapamide—Oxcarbazepine—CYP2C19—epilepsy syndrome	3.94e-05	0.0211	CrCbGaD
Indapamide—Furosemide—ALB—epilepsy syndrome	3.63e-05	0.0194	CrCbGaD
Indapamide—Bumetanide—PTGS2—epilepsy syndrome	3.09e-05	0.0165	CrCbGaD
Indapamide—Oxcarbazepine—ALB—epilepsy syndrome	2.19e-05	0.0117	CrCbGaD
Indapamide—Anorexia—Valproic Acid—epilepsy syndrome	1.36e-05	0.000174	CcSEcCtD
Indapamide—Rash—Diazepam—epilepsy syndrome	1.35e-05	0.000174	CcSEcCtD
Indapamide—Dermatitis—Diazepam—epilepsy syndrome	1.35e-05	0.000173	CcSEcCtD
Indapamide—Visual impairment—Topiramate—epilepsy syndrome	1.35e-05	0.000173	CcSEcCtD
Indapamide—Chest pain—Pregabalin—epilepsy syndrome	1.35e-05	0.000173	CcSEcCtD
Indapamide—Arthralgia—Pregabalin—epilepsy syndrome	1.35e-05	0.000173	CcSEcCtD
Indapamide—Myalgia—Pregabalin—epilepsy syndrome	1.35e-05	0.000173	CcSEcCtD
Indapamide—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.35e-05	0.000173	CcSEcCtD
Indapamide—Dizziness—Zonisamide—epilepsy syndrome	1.35e-05	0.000172	CcSEcCtD
Indapamide—Headache—Diazepam—epilepsy syndrome	1.35e-05	0.000172	CcSEcCtD
Indapamide—Anxiety—Pregabalin—epilepsy syndrome	1.34e-05	0.000172	CcSEcCtD
Indapamide—Diarrhoea—Clonazepam—epilepsy syndrome	1.34e-05	0.000172	CcSEcCtD
Indapamide—Anaemia—Gabapentin—epilepsy syndrome	1.34e-05	0.000172	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.34e-05	0.000171	CcSEcCtD
Indapamide—Hypotension—Valproic Acid—epilepsy syndrome	1.33e-05	0.000171	CcSEcCtD
Indapamide—Asthenia—Carbamazepine—epilepsy syndrome	1.33e-05	0.000171	CcSEcCtD
Indapamide—Agitation—Gabapentin—epilepsy syndrome	1.33e-05	0.000171	CcSEcCtD
Indapamide—Diarrhoea—Phenytoin—epilepsy syndrome	1.33e-05	0.000171	CcSEcCtD
Indapamide—Discomfort—Pregabalin—epilepsy syndrome	1.33e-05	0.000171	CcSEcCtD
Indapamide—Nausea—Fosphenytoin—epilepsy syndrome	1.33e-05	0.00017	CcSEcCtD
Indapamide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.33e-05	0.00017	CcSEcCtD
Indapamide—Erythema multiforme—Topiramate—epilepsy syndrome	1.33e-05	0.00017	CcSEcCtD
Indapamide—Angioedema—Gabapentin—epilepsy syndrome	1.33e-05	0.00017	CcSEcCtD
Indapamide—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.32e-05	0.00017	CcSEcCtD
Indapamide—Vomiting—Felbamate—epilepsy syndrome	1.32e-05	0.000169	CcSEcCtD
Indapamide—Dry mouth—Pregabalin—epilepsy syndrome	1.32e-05	0.000169	CcSEcCtD
Indapamide—Pruritus—Carbamazepine—epilepsy syndrome	1.32e-05	0.000169	CcSEcCtD
Indapamide—Rash—Felbamate—epilepsy syndrome	1.31e-05	0.000168	CcSEcCtD
Indapamide—Dermatitis—Felbamate—epilepsy syndrome	1.31e-05	0.000168	CcSEcCtD
Indapamide—Malaise—Gabapentin—epilepsy syndrome	1.31e-05	0.000168	CcSEcCtD
Indapamide—Tinnitus—Topiramate—epilepsy syndrome	1.31e-05	0.000168	CcSEcCtD
Indapamide—Vertigo—Gabapentin—epilepsy syndrome	1.3e-05	0.000167	CcSEcCtD
Indapamide—Headache—Felbamate—epilepsy syndrome	1.3e-05	0.000167	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.3e-05	0.000167	CcSEcCtD
Indapamide—Flushing—Topiramate—epilepsy syndrome	1.3e-05	0.000167	CcSEcCtD
Indapamide—Cardiac disorder—Topiramate—epilepsy syndrome	1.3e-05	0.000167	CcSEcCtD
Indapamide—Syncope—Gabapentin—epilepsy syndrome	1.3e-05	0.000167	CcSEcCtD
Indapamide—Leukopenia—Gabapentin—epilepsy syndrome	1.3e-05	0.000166	CcSEcCtD
Indapamide—Dizziness—Clonazepam—epilepsy syndrome	1.3e-05	0.000166	CcSEcCtD
Indapamide—Nausea—Vigabatrin—epilepsy syndrome	1.3e-05	0.000166	CcSEcCtD
Indapamide—Vomiting—Zonisamide—epilepsy syndrome	1.29e-05	0.000166	CcSEcCtD
Indapamide—Insomnia—Valproic Acid—epilepsy syndrome	1.29e-05	0.000166	CcSEcCtD
Indapamide—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.29e-05	0.000165	CcSEcCtD
Indapamide—Oedema—Pregabalin—epilepsy syndrome	1.29e-05	0.000165	CcSEcCtD
Indapamide—Asthenia—Lamotrigine—epilepsy syndrome	1.29e-05	0.000165	CcSEcCtD
Indapamide—Dizziness—Phenytoin—epilepsy syndrome	1.29e-05	0.000165	CcSEcCtD
Indapamide—Rash—Zonisamide—epilepsy syndrome	1.28e-05	0.000164	CcSEcCtD
Indapamide—Infection—Pregabalin—epilepsy syndrome	1.28e-05	0.000164	CcSEcCtD
Indapamide—Paraesthesia—Valproic Acid—epilepsy syndrome	1.28e-05	0.000164	CcSEcCtD
Indapamide—Palpitations—Gabapentin—epilepsy syndrome	1.28e-05	0.000164	CcSEcCtD
Indapamide—Dermatitis—Zonisamide—epilepsy syndrome	1.28e-05	0.000164	CcSEcCtD
Indapamide—Dizziness—Oxcarbazepine—epilepsy syndrome	1.28e-05	0.000164	CcSEcCtD
Indapamide—Nausea—Diazepam—epilepsy syndrome	1.28e-05	0.000164	CcSEcCtD
Indapamide—Loss of consciousness—Gabapentin—epilepsy syndrome	1.28e-05	0.000163	CcSEcCtD
Indapamide—Headache—Zonisamide—epilepsy syndrome	1.28e-05	0.000163	CcSEcCtD
Indapamide—Dyspnoea—Valproic Acid—epilepsy syndrome	1.27e-05	0.000163	CcSEcCtD
Indapamide—Diarrhoea—Carbamazepine—epilepsy syndrome	1.27e-05	0.000163	CcSEcCtD
Indapamide—Pruritus—Lamotrigine—epilepsy syndrome	1.27e-05	0.000163	CcSEcCtD
Indapamide—Shock—Pregabalin—epilepsy syndrome	1.27e-05	0.000163	CcSEcCtD
Indapamide—Somnolence—Valproic Acid—epilepsy syndrome	1.27e-05	0.000163	CcSEcCtD
Indapamide—Nervous system disorder—Pregabalin—epilepsy syndrome	1.27e-05	0.000162	CcSEcCtD
Indapamide—Cough—Gabapentin—epilepsy syndrome	1.27e-05	0.000162	CcSEcCtD
Indapamide—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.26e-05	0.000162	CcSEcCtD
Indapamide—Tachycardia—Pregabalin—epilepsy syndrome	1.26e-05	0.000162	CcSEcCtD
Indapamide—Dyspepsia—Valproic Acid—epilepsy syndrome	1.26e-05	0.000161	CcSEcCtD
Indapamide—Skin disorder—Pregabalin—epilepsy syndrome	1.25e-05	0.000161	CcSEcCtD
Indapamide—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.25e-05	0.00016	CcSEcCtD
Indapamide—Vomiting—Clonazepam—epilepsy syndrome	1.25e-05	0.00016	CcSEcCtD
Indapamide—Decreased appetite—Valproic Acid—epilepsy syndrome	1.24e-05	0.000159	CcSEcCtD
Indapamide—Vomiting—Phenytoin—epilepsy syndrome	1.24e-05	0.000159	CcSEcCtD
Indapamide—Rash—Clonazepam—epilepsy syndrome	1.24e-05	0.000159	CcSEcCtD
Indapamide—Dermatitis—Clonazepam—epilepsy syndrome	1.24e-05	0.000158	CcSEcCtD
Indapamide—Arthralgia—Gabapentin—epilepsy syndrome	1.24e-05	0.000158	CcSEcCtD
Indapamide—Myalgia—Gabapentin—epilepsy syndrome	1.24e-05	0.000158	CcSEcCtD
Indapamide—Chest pain—Gabapentin—epilepsy syndrome	1.24e-05	0.000158	CcSEcCtD
Indapamide—Nausea—Felbamate—epilepsy syndrome	1.24e-05	0.000158	CcSEcCtD
Indapamide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.23e-05	0.000158	CcSEcCtD
Indapamide—Vomiting—Oxcarbazepine—epilepsy syndrome	1.23e-05	0.000158	CcSEcCtD
Indapamide—Fatigue—Valproic Acid—epilepsy syndrome	1.23e-05	0.000158	CcSEcCtD
Indapamide—Anxiety—Gabapentin—epilepsy syndrome	1.23e-05	0.000158	CcSEcCtD
Indapamide—Anorexia—Pregabalin—epilepsy syndrome	1.23e-05	0.000158	CcSEcCtD
Indapamide—Dizziness—Carbamazepine—epilepsy syndrome	1.23e-05	0.000158	CcSEcCtD
Indapamide—Diarrhoea—Lamotrigine—epilepsy syndrome	1.23e-05	0.000158	CcSEcCtD
Indapamide—Headache—Clonazepam—epilepsy syndrome	1.23e-05	0.000157	CcSEcCtD
Indapamide—Rash—Phenytoin—epilepsy syndrome	1.23e-05	0.000157	CcSEcCtD
Indapamide—Dermatitis—Phenytoin—epilepsy syndrome	1.23e-05	0.000157	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.23e-05	0.000157	CcSEcCtD
Indapamide—Rash—Oxcarbazepine—epilepsy syndrome	1.22e-05	0.000157	CcSEcCtD
Indapamide—Pain—Valproic Acid—epilepsy syndrome	1.22e-05	0.000157	CcSEcCtD
Indapamide—Constipation—Valproic Acid—epilepsy syndrome	1.22e-05	0.000157	CcSEcCtD
Indapamide—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.22e-05	0.000156	CcSEcCtD
Indapamide—Headache—Phenytoin—epilepsy syndrome	1.22e-05	0.000156	CcSEcCtD
Indapamide—Malnutrition—Topiramate—epilepsy syndrome	1.22e-05	0.000156	CcSEcCtD
Indapamide—Erythema—Topiramate—epilepsy syndrome	1.22e-05	0.000156	CcSEcCtD
Indapamide—Discomfort—Gabapentin—epilepsy syndrome	1.22e-05	0.000156	CcSEcCtD
Indapamide—Headache—Oxcarbazepine—epilepsy syndrome	1.21e-05	0.000156	CcSEcCtD
Indapamide—Nausea—Zonisamide—epilepsy syndrome	1.21e-05	0.000155	CcSEcCtD
Indapamide—Dry mouth—Gabapentin—epilepsy syndrome	1.21e-05	0.000155	CcSEcCtD
Indapamide—Hypotension—Pregabalin—epilepsy syndrome	1.21e-05	0.000155	CcSEcCtD
Indapamide—Flatulence—Topiramate—epilepsy syndrome	1.2e-05	0.000154	CcSEcCtD
Indapamide—Tension—Topiramate—epilepsy syndrome	1.2e-05	0.000154	CcSEcCtD
Indapamide—Dysgeusia—Topiramate—epilepsy syndrome	1.2e-05	0.000153	CcSEcCtD
Indapamide—Dizziness—Lamotrigine—epilepsy syndrome	1.19e-05	0.000152	CcSEcCtD
Indapamide—Nervousness—Topiramate—epilepsy syndrome	1.19e-05	0.000152	CcSEcCtD
Indapamide—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.18e-05	0.000152	CcSEcCtD
Indapamide—Oedema—Gabapentin—epilepsy syndrome	1.18e-05	0.000152	CcSEcCtD
Indapamide—Vomiting—Carbamazepine—epilepsy syndrome	1.18e-05	0.000152	CcSEcCtD
Indapamide—Back pain—Topiramate—epilepsy syndrome	1.18e-05	0.000151	CcSEcCtD
Indapamide—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.18e-05	0.000151	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.18e-05	0.000151	CcSEcCtD
Indapamide—Infection—Gabapentin—epilepsy syndrome	1.18e-05	0.000151	CcSEcCtD
Indapamide—Muscle spasms—Topiramate—epilepsy syndrome	1.17e-05	0.00015	CcSEcCtD
Indapamide—Rash—Carbamazepine—epilepsy syndrome	1.17e-05	0.00015	CcSEcCtD
Indapamide—Dermatitis—Carbamazepine—epilepsy syndrome	1.17e-05	0.00015	CcSEcCtD
Indapamide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.17e-05	0.00015	CcSEcCtD
Indapamide—Insomnia—Pregabalin—epilepsy syndrome	1.17e-05	0.00015	CcSEcCtD
Indapamide—Nausea—Clonazepam—epilepsy syndrome	1.17e-05	0.000149	CcSEcCtD
Indapamide—Headache—Carbamazepine—epilepsy syndrome	1.17e-05	0.000149	CcSEcCtD
Indapamide—Shock—Gabapentin—epilepsy syndrome	1.16e-05	0.000149	CcSEcCtD
Indapamide—Nervous system disorder—Gabapentin—epilepsy syndrome	1.16e-05	0.000149	CcSEcCtD
Indapamide—Paraesthesia—Pregabalin—epilepsy syndrome	1.16e-05	0.000149	CcSEcCtD
Indapamide—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.16e-05	0.000149	CcSEcCtD
Indapamide—Nausea—Phenytoin—epilepsy syndrome	1.16e-05	0.000148	CcSEcCtD
Indapamide—Tachycardia—Gabapentin—epilepsy syndrome	1.16e-05	0.000148	CcSEcCtD
Indapamide—Dyspnoea—Pregabalin—epilepsy syndrome	1.15e-05	0.000148	CcSEcCtD
Indapamide—Nausea—Oxcarbazepine—epilepsy syndrome	1.15e-05	0.000148	CcSEcCtD
Indapamide—Vision blurred—Topiramate—epilepsy syndrome	1.15e-05	0.000147	CcSEcCtD
Indapamide—Skin disorder—Gabapentin—epilepsy syndrome	1.15e-05	0.000147	CcSEcCtD
Indapamide—Somnolence—Pregabalin—epilepsy syndrome	1.15e-05	0.000147	CcSEcCtD
Indapamide—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.14e-05	0.000147	CcSEcCtD
Indapamide—Vomiting—Lamotrigine—epilepsy syndrome	1.14e-05	0.000146	CcSEcCtD
Indapamide—Urticaria—Valproic Acid—epilepsy syndrome	1.13e-05	0.000145	CcSEcCtD
Indapamide—Rash—Lamotrigine—epilepsy syndrome	1.13e-05	0.000145	CcSEcCtD
Indapamide—Ill-defined disorder—Topiramate—epilepsy syndrome	1.13e-05	0.000145	CcSEcCtD
Indapamide—Dermatitis—Lamotrigine—epilepsy syndrome	1.13e-05	0.000145	CcSEcCtD
Indapamide—Body temperature increased—Valproic Acid—epilepsy syndrome	1.13e-05	0.000145	CcSEcCtD
Indapamide—Abdominal pain—Valproic Acid—epilepsy syndrome	1.13e-05	0.000145	CcSEcCtD
Indapamide—Anorexia—Gabapentin—epilepsy syndrome	1.13e-05	0.000145	CcSEcCtD
Indapamide—Anaemia—Topiramate—epilepsy syndrome	1.13e-05	0.000145	CcSEcCtD
Indapamide—Headache—Lamotrigine—epilepsy syndrome	1.13e-05	0.000144	CcSEcCtD
Indapamide—Decreased appetite—Pregabalin—epilepsy syndrome	1.12e-05	0.000144	CcSEcCtD
Indapamide—Agitation—Topiramate—epilepsy syndrome	1.12e-05	0.000144	CcSEcCtD
Indapamide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.11e-05	0.000143	CcSEcCtD
Indapamide—Fatigue—Pregabalin—epilepsy syndrome	1.11e-05	0.000143	CcSEcCtD
Indapamide—Hypotension—Gabapentin—epilepsy syndrome	1.11e-05	0.000142	CcSEcCtD
Indapamide—Nausea—Carbamazepine—epilepsy syndrome	1.1e-05	0.000142	CcSEcCtD
Indapamide—Constipation—Pregabalin—epilepsy syndrome	1.1e-05	0.000142	CcSEcCtD
Indapamide—Pain—Pregabalin—epilepsy syndrome	1.1e-05	0.000142	CcSEcCtD
Indapamide—Malaise—Topiramate—epilepsy syndrome	1.1e-05	0.000141	CcSEcCtD
Indapamide—Vertigo—Topiramate—epilepsy syndrome	1.1e-05	0.000141	CcSEcCtD
Indapamide—Syncope—Topiramate—epilepsy syndrome	1.09e-05	0.00014	CcSEcCtD
Indapamide—Leukopenia—Topiramate—epilepsy syndrome	1.09e-05	0.00014	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.08e-05	0.000138	CcSEcCtD
Indapamide—Palpitations—Topiramate—epilepsy syndrome	1.08e-05	0.000138	CcSEcCtD
Indapamide—Loss of consciousness—Topiramate—epilepsy syndrome	1.07e-05	0.000137	CcSEcCtD
Indapamide—Insomnia—Gabapentin—epilepsy syndrome	1.07e-05	0.000137	CcSEcCtD
Indapamide—Nausea—Lamotrigine—epilepsy syndrome	1.07e-05	0.000137	CcSEcCtD
Indapamide—Cough—Topiramate—epilepsy syndrome	1.07e-05	0.000137	CcSEcCtD
Indapamide—Feeling abnormal—Pregabalin—epilepsy syndrome	1.06e-05	0.000136	CcSEcCtD
Indapamide—Paraesthesia—Gabapentin—epilepsy syndrome	1.06e-05	0.000136	CcSEcCtD
Indapamide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.06e-05	0.000135	CcSEcCtD
Indapamide—Dyspnoea—Gabapentin—epilepsy syndrome	1.06e-05	0.000135	CcSEcCtD
Indapamide—Somnolence—Gabapentin—epilepsy syndrome	1.05e-05	0.000135	CcSEcCtD
Indapamide—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.05e-05	0.000135	CcSEcCtD
Indapamide—Dyspepsia—Gabapentin—epilepsy syndrome	1.04e-05	0.000134	CcSEcCtD
Indapamide—Myalgia—Topiramate—epilepsy syndrome	1.04e-05	0.000133	CcSEcCtD
Indapamide—Chest pain—Topiramate—epilepsy syndrome	1.04e-05	0.000133	CcSEcCtD
Indapamide—Arthralgia—Topiramate—epilepsy syndrome	1.04e-05	0.000133	CcSEcCtD
Indapamide—Anxiety—Topiramate—epilepsy syndrome	1.04e-05	0.000133	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.03e-05	0.000132	CcSEcCtD
Indapamide—Decreased appetite—Gabapentin—epilepsy syndrome	1.03e-05	0.000132	CcSEcCtD
Indapamide—Discomfort—Topiramate—epilepsy syndrome	1.03e-05	0.000132	CcSEcCtD
Indapamide—Urticaria—Pregabalin—epilepsy syndrome	1.03e-05	0.000131	CcSEcCtD
Indapamide—Asthenia—Valproic Acid—epilepsy syndrome	1.02e-05	0.000131	CcSEcCtD
Indapamide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.02e-05	0.000131	CcSEcCtD
Indapamide—Fatigue—Gabapentin—epilepsy syndrome	1.02e-05	0.000131	CcSEcCtD
Indapamide—Body temperature increased—Pregabalin—epilepsy syndrome	1.02e-05	0.000131	CcSEcCtD
Indapamide—Abdominal pain—Pregabalin—epilepsy syndrome	1.02e-05	0.000131	CcSEcCtD
Indapamide—Dry mouth—Topiramate—epilepsy syndrome	1.02e-05	0.00013	CcSEcCtD
Indapamide—Constipation—Gabapentin—epilepsy syndrome	1.01e-05	0.00013	CcSEcCtD
Indapamide—Pain—Gabapentin—epilepsy syndrome	1.01e-05	0.00013	CcSEcCtD
Indapamide—Pruritus—Valproic Acid—epilepsy syndrome	1.01e-05	0.00013	CcSEcCtD
Indapamide—Oedema—Topiramate—epilepsy syndrome	9.96e-06	0.000128	CcSEcCtD
Indapamide—Infection—Topiramate—epilepsy syndrome	9.9e-06	0.000127	CcSEcCtD
Indapamide—Shock—Topiramate—epilepsy syndrome	9.8e-06	0.000126	CcSEcCtD
Indapamide—Diarrhoea—Valproic Acid—epilepsy syndrome	9.77e-06	0.000125	CcSEcCtD
Indapamide—Nervous system disorder—Topiramate—epilepsy syndrome	9.77e-06	0.000125	CcSEcCtD
Indapamide—Feeling abnormal—Gabapentin—epilepsy syndrome	9.76e-06	0.000125	CcSEcCtD
Indapamide—Thrombocytopenia—Topiramate—epilepsy syndrome	9.75e-06	0.000125	CcSEcCtD
Indapamide—Tachycardia—Topiramate—epilepsy syndrome	9.72e-06	0.000125	CcSEcCtD
Indapamide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	9.68e-06	0.000124	CcSEcCtD
Indapamide—Skin disorder—Topiramate—epilepsy syndrome	9.68e-06	0.000124	CcSEcCtD
Indapamide—Hyperhidrosis—Topiramate—epilepsy syndrome	9.63e-06	0.000123	CcSEcCtD
Indapamide—Hypersensitivity—Pregabalin—epilepsy syndrome	9.51e-06	0.000122	CcSEcCtD
Indapamide—Anorexia—Topiramate—epilepsy syndrome	9.5e-06	0.000122	CcSEcCtD
Indapamide—Dizziness—Valproic Acid—epilepsy syndrome	9.45e-06	0.000121	CcSEcCtD
Indapamide—Urticaria—Gabapentin—epilepsy syndrome	9.41e-06	0.000121	CcSEcCtD
Indapamide—Body temperature increased—Gabapentin—epilepsy syndrome	9.36e-06	0.00012	CcSEcCtD
Indapamide—Abdominal pain—Gabapentin—epilepsy syndrome	9.36e-06	0.00012	CcSEcCtD
Indapamide—Hypotension—Topiramate—epilepsy syndrome	9.31e-06	0.000119	CcSEcCtD
Indapamide—Asthenia—Pregabalin—epilepsy syndrome	9.26e-06	0.000119	CcSEcCtD
Indapamide—SLC12A3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	9.18e-06	0.000214	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	9.17e-06	0.000214	CbGpPWpGaD
Indapamide—CA9—Metabolism—HSD17B4—epilepsy syndrome	9.17e-06	0.000214	CbGpPWpGaD
Indapamide—Pruritus—Pregabalin—epilepsy syndrome	9.14e-06	0.000117	CcSEcCtD
Indapamide—CA4—Metabolism—ST3GAL3—epilepsy syndrome	9.12e-06	0.000213	CbGpPWpGaD
Indapamide—Vomiting—Valproic Acid—epilepsy syndrome	9.08e-06	0.000116	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	9.08e-06	0.000116	CcSEcCtD
Indapamide—Insomnia—Topiramate—epilepsy syndrome	9.01e-06	0.000115	CcSEcCtD
Indapamide—Rash—Valproic Acid—epilepsy syndrome	9.01e-06	0.000115	CcSEcCtD
Indapamide—Dermatitis—Valproic Acid—epilepsy syndrome	9e-06	0.000115	CcSEcCtD
Indapamide—Headache—Valproic Acid—epilepsy syndrome	8.95e-06	0.000115	CcSEcCtD
Indapamide—Paraesthesia—Topiramate—epilepsy syndrome	8.95e-06	0.000115	CcSEcCtD
Indapamide—CA2—Metabolism—ALDH7A1—epilepsy syndrome	8.93e-06	0.000209	CbGpPWpGaD
Indapamide—CA2—Metabolism—CACNA1A—epilepsy syndrome	8.93e-06	0.000209	CbGpPWpGaD
Indapamide—CA4—Metabolism—ADSL—epilepsy syndrome	8.93e-06	0.000209	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	8.89e-06	0.000208	CbGpPWpGaD
Indapamide—Dyspnoea—Topiramate—epilepsy syndrome	8.88e-06	0.000114	CcSEcCtD
Indapamide—Somnolence—Topiramate—epilepsy syndrome	8.86e-06	0.000113	CcSEcCtD
Indapamide—CA9—Metabolism—GBE1—epilepsy syndrome	8.85e-06	0.000207	CbGpPWpGaD
Indapamide—CA9—Metabolism—PPP1R3C—epilepsy syndrome	8.85e-06	0.000207	CbGpPWpGaD
Indapamide—CA12—Metabolism—KCNJ11—epilepsy syndrome	8.85e-06	0.000207	CbGpPWpGaD
Indapamide—CA12—Metabolism—CHRM3—epilepsy syndrome	8.85e-06	0.000207	CbGpPWpGaD
Indapamide—Diarrhoea—Pregabalin—epilepsy syndrome	8.83e-06	0.000113	CcSEcCtD
Indapamide—Dyspepsia—Topiramate—epilepsy syndrome	8.77e-06	0.000112	CcSEcCtD
Indapamide—CA4—Metabolism—GLUL—epilepsy syndrome	8.76e-06	0.000205	CbGpPWpGaD
Indapamide—CA2—Metabolism—ST3GAL3—epilepsy syndrome	8.74e-06	0.000204	CbGpPWpGaD
Indapamide—Hypersensitivity—Gabapentin—epilepsy syndrome	8.72e-06	0.000112	CcSEcCtD
Indapamide—Decreased appetite—Topiramate—epilepsy syndrome	8.66e-06	0.000111	CcSEcCtD
Indapamide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	8.6e-06	0.00011	CcSEcCtD
Indapamide—CA4—Metabolism—CACNA1D—epilepsy syndrome	8.6e-06	0.000201	CbGpPWpGaD
Indapamide—Fatigue—Topiramate—epilepsy syndrome	8.59e-06	0.00011	CcSEcCtD
Indapamide—CA2—Metabolism—ADSL—epilepsy syndrome	8.56e-06	0.0002	CbGpPWpGaD
Indapamide—Dizziness—Pregabalin—epilepsy syndrome	8.54e-06	0.000109	CcSEcCtD
Indapamide—Constipation—Topiramate—epilepsy syndrome	8.52e-06	0.000109	CcSEcCtD
Indapamide—Pain—Topiramate—epilepsy syndrome	8.52e-06	0.000109	CcSEcCtD
Indapamide—Asthenia—Gabapentin—epilepsy syndrome	8.5e-06	0.000109	CcSEcCtD
Indapamide—Nausea—Valproic Acid—epilepsy syndrome	8.48e-06	0.000109	CcSEcCtD
Indapamide—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	8.44e-06	0.000197	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	8.4e-06	0.000196	CbGpPWpGaD
Indapamide—CA2—Metabolism—GLUL—epilepsy syndrome	8.4e-06	0.000196	CbGpPWpGaD
Indapamide—Pruritus—Gabapentin—epilepsy syndrome	8.38e-06	0.000107	CcSEcCtD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	8.35e-06	0.000195	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ABCG2—epilepsy syndrome	8.34e-06	0.000195	CbGpPWpGaD
Indapamide—CA9—Metabolism—ASAH1—epilepsy syndrome	8.32e-06	0.000194	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—FOS—epilepsy syndrome	8.28e-06	0.000193	CbGpPWpGaD
Indapamide—CA2—Metabolism—CACNA1D—epilepsy syndrome	8.24e-06	0.000193	CbGpPWpGaD
Indapamide—Vomiting—Pregabalin—epilepsy syndrome	8.21e-06	0.000105	CcSEcCtD
Indapamide—Feeling abnormal—Topiramate—epilepsy syndrome	8.21e-06	0.000105	CcSEcCtD
Indapamide—Gastrointestinal pain—Topiramate—epilepsy syndrome	8.15e-06	0.000104	CcSEcCtD
Indapamide—Rash—Pregabalin—epilepsy syndrome	8.14e-06	0.000104	CcSEcCtD
Indapamide—Dermatitis—Pregabalin—epilepsy syndrome	8.13e-06	0.000104	CcSEcCtD
Indapamide—CA5A—Metabolism—CYP2C19—epilepsy syndrome	8.13e-06	0.00019	CbGpPWpGaD
Indapamide—Diarrhoea—Gabapentin—epilepsy syndrome	8.1e-06	0.000104	CcSEcCtD
Indapamide—CA9—Metabolism—STXBP1—epilepsy syndrome	8.1e-06	0.000189	CbGpPWpGaD
Indapamide—Headache—Pregabalin—epilepsy syndrome	8.09e-06	0.000104	CcSEcCtD
Indapamide—CA5A—Metabolism—CYP11A1—epilepsy syndrome	8.08e-06	0.000189	CbGpPWpGaD
Indapamide—CA4—Metabolism—TXNRD1—epilepsy syndrome	8.04e-06	0.000188	CbGpPWpGaD
Indapamide—Urticaria—Topiramate—epilepsy syndrome	7.91e-06	0.000101	CcSEcCtD
Indapamide—CA9—Metabolism—NT5E—epilepsy syndrome	7.89e-06	0.000184	CbGpPWpGaD
Indapamide—CA9—Metabolism—ALAD—epilepsy syndrome	7.89e-06	0.000184	CbGpPWpGaD
Indapamide—Body temperature increased—Topiramate—epilepsy syndrome	7.87e-06	0.000101	CcSEcCtD
Indapamide—Abdominal pain—Topiramate—epilepsy syndrome	7.87e-06	0.000101	CcSEcCtD
Indapamide—Dizziness—Gabapentin—epilepsy syndrome	7.83e-06	0.0001	CcSEcCtD
Indapamide—CA4—Metabolism—AQP1—epilepsy syndrome	7.81e-06	0.000182	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ABCG2—epilepsy syndrome	7.79e-06	0.000182	CbGpPWpGaD
Indapamide—CA7—Metabolism—ABCG2—epilepsy syndrome	7.79e-06	0.000182	CbGpPWpGaD
Indapamide—CA2—Metabolism—TXNRD1—epilepsy syndrome	7.71e-06	0.00018	CbGpPWpGaD
Indapamide—Nausea—Pregabalin—epilepsy syndrome	7.67e-06	9.83e-05	CcSEcCtD
Indapamide—CA7—Metabolism—CYP2C19—epilepsy syndrome	7.59e-06	0.000177	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP2C19—epilepsy syndrome	7.59e-06	0.000177	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP11A1—epilepsy syndrome	7.54e-06	0.000176	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP11A1—epilepsy syndrome	7.54e-06	0.000176	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	7.53e-06	0.000176	CbGpPWpGaD
Indapamide—Vomiting—Gabapentin—epilepsy syndrome	7.53e-06	9.65e-05	CcSEcCtD
Indapamide—CA9—Metabolism—ALDH7A1—epilepsy syndrome	7.53e-06	0.000176	CbGpPWpGaD
Indapamide—CA9—Metabolism—CACNA1A—epilepsy syndrome	7.53e-06	0.000176	CbGpPWpGaD
Indapamide—CA2—Metabolism—AQP1—epilepsy syndrome	7.48e-06	0.000175	CbGpPWpGaD
Indapamide—Rash—Gabapentin—epilepsy syndrome	7.47e-06	9.57e-05	CcSEcCtD
Indapamide—Dermatitis—Gabapentin—epilepsy syndrome	7.46e-06	9.56e-05	CcSEcCtD
Indapamide—Headache—Gabapentin—epilepsy syndrome	7.42e-06	9.51e-05	CcSEcCtD
Indapamide—CA9—Metabolism—ST3GAL3—epilepsy syndrome	7.37e-06	0.000172	CbGpPWpGaD
Indapamide—Hypersensitivity—Topiramate—epilepsy syndrome	7.34e-06	9.41e-05	CcSEcCtD
Indapamide—CA5A—Metabolism—CYP2D6—epilepsy syndrome	7.29e-06	0.00017	CbGpPWpGaD
Indapamide—CA9—Metabolism—ADSL—epilepsy syndrome	7.22e-06	0.000169	CbGpPWpGaD
Indapamide—CA12—Metabolism—ABCG2—epilepsy syndrome	7.22e-06	0.000169	CbGpPWpGaD
Indapamide—Asthenia—Topiramate—epilepsy syndrome	7.15e-06	9.16e-05	CcSEcCtD
Indapamide—CA9—Metabolism—GLUL—epilepsy syndrome	7.08e-06	0.000165	CbGpPWpGaD
Indapamide—CA4—Metabolism—CHRM3—epilepsy syndrome	7.06e-06	0.000165	CbGpPWpGaD
Indapamide—CA4—Metabolism—KCNJ11—epilepsy syndrome	7.06e-06	0.000165	CbGpPWpGaD
Indapamide—Pruritus—Topiramate—epilepsy syndrome	7.05e-06	9.03e-05	CcSEcCtD
Indapamide—Nausea—Gabapentin—epilepsy syndrome	7.03e-06	9.01e-05	CcSEcCtD
Indapamide—CA12—Metabolism—CYP2C19—epilepsy syndrome	7.03e-06	0.000164	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP11A1—epilepsy syndrome	6.99e-06	0.000163	CbGpPWpGaD
Indapamide—CA9—Metabolism—CACNA1D—epilepsy syndrome	6.95e-06	0.000162	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ADRA2A—epilepsy syndrome	6.94e-06	0.000162	CbGpPWpGaD
Indapamide—CA5A—Metabolism—BCHE—epilepsy syndrome	6.91e-06	0.000162	CbGpPWpGaD
Indapamide—Diarrhoea—Topiramate—epilepsy syndrome	6.82e-06	8.74e-05	CcSEcCtD
Indapamide—CA7—Metabolism—CYP2D6—epilepsy syndrome	6.81e-06	0.000159	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP2D6—epilepsy syndrome	6.81e-06	0.000159	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—RELA—epilepsy syndrome	6.79e-06	0.000159	CbGpPWpGaD
Indapamide—CA2—Metabolism—KCNJ11—epilepsy syndrome	6.77e-06	0.000158	CbGpPWpGaD
Indapamide—CA2—Metabolism—CHRM3—epilepsy syndrome	6.77e-06	0.000158	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—MTOR—epilepsy syndrome	6.65e-06	0.000155	CbGpPWpGaD
Indapamide—CA5A—Metabolism—SLC2A1—epilepsy syndrome	6.6e-06	0.000154	CbGpPWpGaD
Indapamide—Dizziness—Topiramate—epilepsy syndrome	6.59e-06	8.44e-05	CcSEcCtD
Indapamide—CA5A—Metabolism—PLCB1—epilepsy syndrome	6.52e-06	0.000152	CbGpPWpGaD
Indapamide—CA5A—Metabolism—TH—epilepsy syndrome	6.5e-06	0.000152	CbGpPWpGaD
Indapamide—CA9—Metabolism—TXNRD1—epilepsy syndrome	6.5e-06	0.000152	CbGpPWpGaD
Indapamide—CA7—Metabolism—ADRA2A—epilepsy syndrome	6.48e-06	0.000151	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ADRA2A—epilepsy syndrome	6.48e-06	0.000151	CbGpPWpGaD
Indapamide—CA7—Metabolism—BCHE—epilepsy syndrome	6.46e-06	0.000151	CbGpPWpGaD
Indapamide—CA5B—Metabolism—BCHE—epilepsy syndrome	6.46e-06	0.000151	CbGpPWpGaD
Indapamide—Vomiting—Topiramate—epilepsy syndrome	6.33e-06	8.12e-05	CcSEcCtD
Indapamide—CA12—Metabolism—CYP2D6—epilepsy syndrome	6.31e-06	0.000147	CbGpPWpGaD
Indapamide—CA9—Metabolism—AQP1—epilepsy syndrome	6.31e-06	0.000147	CbGpPWpGaD
Indapamide—Rash—Topiramate—epilepsy syndrome	6.28e-06	8.05e-05	CcSEcCtD
Indapamide—Dermatitis—Topiramate—epilepsy syndrome	6.28e-06	8.04e-05	CcSEcCtD
Indapamide—Headache—Topiramate—epilepsy syndrome	6.24e-06	8e-05	CcSEcCtD
Indapamide—CA7—Metabolism—SLC2A1—epilepsy syndrome	6.16e-06	0.000144	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SLC2A1—epilepsy syndrome	6.16e-06	0.000144	CbGpPWpGaD
Indapamide—CA7—Metabolism—PLCB1—epilepsy syndrome	6.09e-06	0.000142	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PLCB1—epilepsy syndrome	6.09e-06	0.000142	CbGpPWpGaD
Indapamide—CA5B—Metabolism—TH—epilepsy syndrome	6.07e-06	0.000142	CbGpPWpGaD
Indapamide—CA7—Metabolism—TH—epilepsy syndrome	6.07e-06	0.000142	CbGpPWpGaD
Indapamide—CA12—Metabolism—ADRA2A—epilepsy syndrome	6.01e-06	0.00014	CbGpPWpGaD
Indapamide—CA12—Metabolism—BCHE—epilepsy syndrome	5.98e-06	0.00014	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—JUN—epilepsy syndrome	5.94e-06	0.000139	CbGpPWpGaD
Indapamide—Nausea—Topiramate—epilepsy syndrome	5.92e-06	7.58e-05	CcSEcCtD
Indapamide—CA4—Metabolism—ABCG2—epilepsy syndrome	5.76e-06	0.000134	CbGpPWpGaD
Indapamide—CA9—Metabolism—CHRM3—epilepsy syndrome	5.7e-06	0.000133	CbGpPWpGaD
Indapamide—CA9—Metabolism—KCNJ11—epilepsy syndrome	5.7e-06	0.000133	CbGpPWpGaD
Indapamide—CA12—Metabolism—SLC2A1—epilepsy syndrome	5.7e-06	0.000133	CbGpPWpGaD
Indapamide—CA12—Metabolism—PLCB1—epilepsy syndrome	5.64e-06	0.000132	CbGpPWpGaD
Indapamide—CA12—Metabolism—TH—epilepsy syndrome	5.62e-06	0.000131	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP2C19—epilepsy syndrome	5.61e-06	0.000131	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP11A1—epilepsy syndrome	5.57e-06	0.00013	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.56e-06	0.00013	CbGpPWpGaD
Indapamide—CA2—Metabolism—ABCG2—epilepsy syndrome	5.52e-06	0.000129	CbGpPWpGaD
Indapamide—CA5A—Metabolism—HMOX1—epilepsy syndrome	5.43e-06	0.000127	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP2C19—epilepsy syndrome	5.38e-06	0.000126	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CAT—epilepsy syndrome	5.35e-06	0.000125	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP11A1—epilepsy syndrome	5.34e-06	0.000125	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ABCB1—epilepsy syndrome	5.21e-06	0.000122	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—VEGFA—epilepsy syndrome	5.19e-06	0.000121	CbGpPWpGaD
Indapamide—CA5B—Metabolism—HMOX1—epilepsy syndrome	5.07e-06	0.000118	CbGpPWpGaD
Indapamide—CA7—Metabolism—HMOX1—epilepsy syndrome	5.07e-06	0.000118	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP2D6—epilepsy syndrome	5.03e-06	0.000118	CbGpPWpGaD
Indapamide—CA7—Metabolism—CAT—epilepsy syndrome	5e-06	0.000117	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CAT—epilepsy syndrome	5e-06	0.000117	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ABCB1—epilepsy syndrome	4.86e-06	0.000114	CbGpPWpGaD
Indapamide—CA7—Metabolism—ABCB1—epilepsy syndrome	4.86e-06	0.000114	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GPX1—epilepsy syndrome	4.84e-06	0.000113	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP2D6—epilepsy syndrome	4.82e-06	0.000113	CbGpPWpGaD
Indapamide—CA4—Metabolism—ADRA2A—epilepsy syndrome	4.79e-06	0.000112	CbGpPWpGaD
Indapamide—CA4—Metabolism—BCHE—epilepsy syndrome	4.77e-06	0.000111	CbGpPWpGaD
Indapamide—CA12—Metabolism—HMOX1—epilepsy syndrome	4.69e-06	0.00011	CbGpPWpGaD
Indapamide—CA9—Metabolism—ABCG2—epilepsy syndrome	4.65e-06	0.000109	CbGpPWpGaD
Indapamide—CA12—Metabolism—CAT—epilepsy syndrome	4.63e-06	0.000108	CbGpPWpGaD
Indapamide—CA2—Metabolism—ADRA2A—epilepsy syndrome	4.59e-06	0.000107	CbGpPWpGaD
Indapamide—CA2—Metabolism—BCHE—epilepsy syndrome	4.57e-06	0.000107	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	4.55e-06	0.000106	CbGpPWpGaD
Indapamide—CA4—Metabolism—SLC2A1—epilepsy syndrome	4.55e-06	0.000106	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP2C19—epilepsy syndrome	4.53e-06	0.000106	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GPX1—epilepsy syndrome	4.52e-06	0.000106	CbGpPWpGaD
Indapamide—CA7—Metabolism—GPX1—epilepsy syndrome	4.52e-06	0.000106	CbGpPWpGaD
Indapamide—CA12—Metabolism—ABCB1—epilepsy syndrome	4.5e-06	0.000105	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP11A1—epilepsy syndrome	4.5e-06	0.000105	CbGpPWpGaD
Indapamide—CA4—Metabolism—PLCB1—epilepsy syndrome	4.5e-06	0.000105	CbGpPWpGaD
Indapamide—CA4—Metabolism—TH—epilepsy syndrome	4.48e-06	0.000105	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	4.46e-06	0.000104	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	4.43e-06	0.000104	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	4.4e-06	0.000103	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	4.37e-06	0.000102	CbGpPWpGaD
Indapamide—CA2—Metabolism—SLC2A1—epilepsy syndrome	4.36e-06	0.000102	CbGpPWpGaD
Indapamide—CA2—Metabolism—PLCB1—epilepsy syndrome	4.31e-06	0.000101	CbGpPWpGaD
Indapamide—CA2—Metabolism—TH—epilepsy syndrome	4.3e-06	0.0001	CbGpPWpGaD
Indapamide—CA5A—Metabolism—AGT—epilepsy syndrome	4.25e-06	9.92e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—GPX1—epilepsy syndrome	4.19e-06	9.78e-05	CbGpPWpGaD
Indapamide—CA5A—Metabolism—APOE—epilepsy syndrome	4.16e-06	9.72e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP2D6—epilepsy syndrome	4.06e-06	9.5e-05	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	4e-06	9.35e-05	CbGpPWpGaD
Indapamide—CA5B—Metabolism—AGT—epilepsy syndrome	3.96e-06	9.26e-05	CbGpPWpGaD
Indapamide—CA7—Metabolism—AGT—epilepsy syndrome	3.96e-06	9.26e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.95e-06	9.22e-05	CbGpPWpGaD
Indapamide—CA7—Metabolism—APOE—epilepsy syndrome	3.88e-06	9.07e-05	CbGpPWpGaD
Indapamide—CA5B—Metabolism—APOE—epilepsy syndrome	3.88e-06	9.07e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—ADRA2A—epilepsy syndrome	3.87e-06	9.04e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—BCHE—epilepsy syndrome	3.85e-06	9e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—HMOX1—epilepsy syndrome	3.74e-06	8.74e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—CAT—epilepsy syndrome	3.69e-06	8.63e-05	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.69e-06	8.62e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—SLC2A1—epilepsy syndrome	3.68e-06	8.59e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—AGT—epilepsy syndrome	3.67e-06	8.58e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PLCB1—epilepsy syndrome	3.64e-06	8.5e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—TH—epilepsy syndrome	3.62e-06	8.47e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—APOE—epilepsy syndrome	3.6e-06	8.41e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—ABCB1—epilepsy syndrome	3.59e-06	8.39e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—HMOX1—epilepsy syndrome	3.59e-06	8.38e-05	CbGpPWpGaD
Indapamide—CA5A—Metabolism—POMC—epilepsy syndrome	3.57e-06	8.35e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—CAT—epilepsy syndrome	3.54e-06	8.27e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—ABCB1—epilepsy syndrome	3.44e-06	8.05e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—GPX1—epilepsy syndrome	3.34e-06	7.8e-05	CbGpPWpGaD
Indapamide—CA5B—Metabolism—POMC—epilepsy syndrome	3.34e-06	7.79e-05	CbGpPWpGaD
Indapamide—CA7—Metabolism—POMC—epilepsy syndrome	3.34e-06	7.79e-05	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ALB—epilepsy syndrome	3.26e-06	7.61e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—GPX1—epilepsy syndrome	3.2e-06	7.48e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—POMC—epilepsy syndrome	3.09e-06	7.22e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CA13—epilepsy syndrome	3.05e-06	7.13e-05	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ALB—epilepsy syndrome	3.04e-06	7.11e-05	CbGpPWpGaD
Indapamide—CA7—Metabolism—ALB—epilepsy syndrome	3.04e-06	7.11e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—HMOX1—epilepsy syndrome	3.02e-06	7.07e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—CAT—epilepsy syndrome	2.98e-06	6.97e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—AGT—epilepsy syndrome	2.93e-06	6.84e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—ABCB1—epilepsy syndrome	2.9e-06	6.78e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—APOE—epilepsy syndrome	2.87e-06	6.7e-05	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTGS2—epilepsy syndrome	2.85e-06	6.66e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—ALB—epilepsy syndrome	2.82e-06	6.58e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—AGT—epilepsy syndrome	2.81e-06	6.56e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—APOE—epilepsy syndrome	2.75e-06	6.43e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—GPX1—epilepsy syndrome	2.7e-06	6.3e-05	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTGS2—epilepsy syndrome	2.66e-06	6.22e-05	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS2—epilepsy syndrome	2.66e-06	6.22e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS2—epilepsy syndrome	2.47e-06	5.76e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—POMC—epilepsy syndrome	2.46e-06	5.76e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—AGT—epilepsy syndrome	2.37e-06	5.53e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—POMC—epilepsy syndrome	2.36e-06	5.52e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—APOE—epilepsy syndrome	2.32e-06	5.42e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	2.31e-06	5.4e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	2.31e-06	5.4e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ADK—epilepsy syndrome	2.31e-06	5.4e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	2.31e-06	5.4e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	2.31e-06	5.4e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	2.31e-06	5.4e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—ALB—epilepsy syndrome	2.25e-06	5.25e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—ALB—epilepsy syndrome	2.15e-06	5.03e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	2.12e-06	4.94e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	2.12e-06	4.94e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	2.12e-06	4.94e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	2.12e-06	4.94e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—POMC—epilepsy syndrome	1.99e-06	4.65e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.97e-06	4.6e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.97e-06	4.6e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS2—epilepsy syndrome	1.97e-06	4.59e-05	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.96e-06	4.58e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS2—epilepsy syndrome	1.88e-06	4.4e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.85e-06	4.32e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—ALB—epilepsy syndrome	1.82e-06	4.24e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.75e-06	4.1e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.75e-06	4.1e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.75e-06	4.1e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.75e-06	4.1e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.75e-06	4.1e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.6e-06	3.75e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.6e-06	3.75e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.6e-06	3.75e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS2—epilepsy syndrome	1.59e-06	3.71e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.54e-06	3.61e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.49e-06	3.48e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.49e-06	3.48e-05	CbGpPWpGaD
Indapamide—CA5A—Metabolism—AKT1—epilepsy syndrome	1.43e-06	3.35e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.4e-06	3.27e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.36e-06	3.19e-05	CbGpPWpGaD
Indapamide—CA5B—Metabolism—AKT1—epilepsy syndrome	1.34e-06	3.12e-05	CbGpPWpGaD
Indapamide—CA7—Metabolism—AKT1—epilepsy syndrome	1.34e-06	3.12e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.33e-06	3.1e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.33e-06	3.1e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.27e-06	2.96e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.27e-06	2.96e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.24e-06	2.9e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—AKT1—epilepsy syndrome	1.24e-06	2.89e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.21e-06	2.84e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.19e-06	2.78e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.17e-06	2.73e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.09e-06	2.56e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.06e-06	2.48e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—AKT1—epilepsy syndrome	9.88e-07	2.31e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	9.6e-07	2.24e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	9.6e-07	2.24e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—AKT1—epilepsy syndrome	9.47e-07	2.21e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—AKT1—epilepsy syndrome	7.98e-07	1.87e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.83e-07	1.83e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	7.63e-07	1.78e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	7.58e-07	1.77e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.84e-07	1.6e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6.51e-07	1.52e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	6.49e-07	1.52e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	6.19e-07	1.45e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	6.12e-07	1.43e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TH—epilepsy syndrome	6.1e-07	1.43e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.09e-07	1.19e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CAT—epilepsy syndrome	5.02e-07	1.17e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.89e-07	1.14e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.54e-07	1.06e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.98e-07	9.31e-06	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.9e-07	9.12e-06	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.35e-07	7.83e-06	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.06e-07	7.14e-06	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.67e-07	6.25e-06	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.34e-07	3.14e-06	CbGpPWpGaD
